Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

Historical Holders from Q1 2021 to Q1 2025

Symbol
ACHL
CUSIP
00449L102
Type / Class
Equity / American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share
Shares outstanding
41.1M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
24.3M
Holdings value
$27.7M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
21
Number of buys
5
Number of sells
-9
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BML Investment Partners, L.P. 9.97% $5.82M 4.1M BML Investment Partners, L.P. Dec 31, 2024

Institutional Holders of Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 15.3K $22.3K +$1.19K $1.48 3
2024 Q4 24.3M $27.7M -$94K $1.14 21
2024 Q3 24.3M $24.8M +$1.85M $1.02 22
2024 Q2 22.2M $18.1M -$1.75M $0.82 26
2024 Q1 23.5M $29.4M +$2.65M $1.25 31
2023 Q4 21.8M $19.4M -$318K $0.89 19
2023 Q3 19.7M $17.9M -$91.1K $0.91 16
2023 Q2 19.8M $18.7M -$523K $0.95 16
2023 Q1 20.2M $19.4M -$1.27M $0.96 16
2022 Q4 21.7M $19.5M -$7.99M $0.90 21
2022 Q3 27.3M $61.6M +$232K $2.26 23
2022 Q2 27.1M $68.3M +$1.41M $2.52 21
2022 Q1 15.5M $45.5M -$4.27M $2.94 20
2021 Q4 27.4M $137M -$13M $5.01 28
2021 Q3 17.6M $137M -$11.4M $7.79 19
2021 Q2 18.8M $184M +$18.2M $9.79 29
2021 Q1 16.8M $278M +$278M $16.55 29